Archive for the ‘Central Nervous System Infections’ Category

Introduction

Wednesday, June 3rd, 2015

The major clinical syndromes of central nervous system infections include the following:

  1. Meningitis: inflammation of the leptomeninges (arachnoid and pia mater)
  2. Encephalitis: inflammation of brain parenchyma
  3. Brain abscess
  4. Subdural empyema and epidural abscess
  5. Suppurative intracranial thrombophlebitis
  6. Shunt infection

Meningitis

Tuesday, June 3rd, 2014

A. Clinical Manifestations

The classic triad of fever, headache and meningeal irritation (neck stiffness) sometimes do not occur altogether. Occasionally, patients may also have altered sensorium. Meningitis can be classified into acute, subacute, and chronic meningitis. Acute meningitis is characterized by onset of symptoms over the course of hours to up to several days. Subacute meningitis often has insidious onset. By definition, chronic meningitis would have compatible symptoms for at least 4 weeks.

B. Aetiology

The aetiological agents that can cause meningitis include bacteria, viruses, fungi, and even parasites. Patients in different age groups who have different underlying predispositions and environmental exposures would have different pathogens. In general, acute meningitis is usually caused by bacteria or viruses, while subacute or chronic meningitis are usually caused by mycobacteria, fungi, or atypical bacteria.

i) Acute meningitis:

Common causes of acute pyogenic meningitis:

Age 0 – 8 weeks Escherichia coli (K1)
Streptococcus agalactiae (group B type III)
Listeria monocytogenes
Other Enterobacteriaceae eg. Salmonella sp.
3 months – 18 years Haemophilus influenzae serotype b*
Neisseria meningitidis
Streptococcus pneumoniae
18 years – 50 years Streptococcus pneumoniae
Neisseria meningitidis
> 50 years Above 2 and aerobic Gram-negative bacilli (e.g. Klebsiella sp., Escherichia sp., Salmonella sp.)
Immunocompromised hosts Above 3 and Listeria monocytogenes, Pseudomonas aeruginosa
Occupational / exposure to pigs Streptococcus suis
Exposure to contaminated fresh water Nagleria fowleri & other free-living amoeba (high mortality)
Ingestion of raw mollusk Angiostrongylus cantonensis (eosinophilic meningitis)
Head trauma, intrathecal injection and post-neurosurgery Staphylococcus aureus
Staphylococcus epidermidis
Aerobic Gram-negative bacilli
Aspergillus sp.; other molds
Post-shunting Above 3 and Proprionibacterium acne

* Meningitis due to Haemophilus influenzae b has reduced markedly after routine immunization was introduced in some countires

The type of organism can be predicted by the route of acquisition of organisms and immune status. Common causes of viral meningitis is often the cause of acute encephalitis and include enteroviruses, Japanese encephalitis virus, mumps virus, herpes simplex types 1 & 2, varicella zoster virus and often as part of an infectious mononucleosis-like syndrome: human immunodeficiency virus (HIV), cytomegalovirus (CMV) and Epstein-Barr virus (EBV).

ii) Subacute to chronic meningitis:

Common etiological agents of subacute and chronic meningitis include:

1)        Mycobacterium tuberculosis

2)        Cryptococcus neoformans

3)        Treponema pallidum (syphilis)

4)        Borrelia burgdorferi (Lyme’s disease)

5)        Nocardia sp. (most patients are immunosuppressed)

6)        Others: dimorphic fungi, Candida sp., Acanthamoeba sp., Angiostrongylus sp., Brucella sp.

Tuberculous meningitis:

This often results from the rupture of a superficial infective granuloma on the pia mater into the subarachnoid space. Young patients often have concomitant progressive pulmonary / systemic disease whereas older patients may have no other clinically evident foci.

Cryptococcal meningitis:

Patients with cryptococcal meningitis often present with a subacute onset of headache and dementia. 50% of these patients have an underlying immunodeficiency disorder, e.g. AIDS, lymphoma, receiving immunosuppressant therapy (such as steroids), had a history of transplantation etc.

C. Diagnosis

The diagnosis of meningitis depends on the examination of the CSF. CSF should be sent for cell count and differential count, glucose and protein. Microbiological investigations including Gram smear, bacterial culture, Ziehl-Neelson smear, mycobacterial culture, Indian ink examination, fungal culture, rapid bacterial antigen detection (Group B Streptococcus, E. coli K1, Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae type b), VDRL for syphilis, PCR/RT-PCR for Mycobacterium tuberculosis, herpes simplex virus, and enterovirus, viral culture, and even wet mount should be considered depending on the clinical scenario. A minimal of 10 mL CSF should be collected (especially if various investigations are required).

Typical CSF findings

Cause WBC (cells/mm3) Cell type Glucose (mg/dL) Protein (mg/dL)
Viral 50–1000 Mononuclear >45 <200
Bacterial 1000–5000 Polymorphonuclear <40 100–500
Tuberculosis 50–300 Mononuclear <45 50–300
(or higher)
Cryptococcus 20–500 Mononuclear <40 >45

Typical CSF findings in patients with tuberculous meningitis:

  1. Fluctuating cerebrospinal fluid (CSF) findings
  2. Lymphocytic /mononuclear pleocytosis of 50 to 300 cells (except in very early stage when polymorphs dominate)
  3. High protein, low CSF to serum glucose level
  4. Zeihl-Neelsen smear positive (<15%, Figure 1)
  5. CSF culture positive (<50%)
  6. Sputum culture positive (<30%)

Figure 1. Presence of acid fast bacilli can be seen when the CSF is being stained with Zeihl-Neelsen stain

Typical CSF findings in patients with cryptococcal meningitis:

  1. Lymphocytic /mononuclear pleocytosis (20 to 500 cells)
  2. High protein, low CSF to serum glucose level (55%)
  3. Positive Indian ink examination (50%, Figure 2)
  4. Positive CSF cryptococcal antigen (85%)
  5. Positive serum cryptococcal antigen and / or CSF antigen (94%)
  6. Positive fungal culture (90%)

Figure 2. CSF microscopy findings of a patient with cryptoccocal meningitis. An area of ‘negative stain’ can be appreciated when the CSF is smeared with Indian ink. This corresponds to the large halo of capsular material which encloses the budding yeast.

D. Management

The current management strategies consist of early use of empirical antibiotics +/- steroids. The antibiotic regimen should be able to penetrate the blood-brain barrier and therefore a high dose of antibiotics is usually necessary. The regimen can then be later guided by culture results when they are available. It is necessary to watch out for complications (e.g. hydrocephalus, stroke, and seizures). For conditions which are often associated with hydrocephalus (e.g. cryptococcal meningitis), repeated lumbar puncture +/- shunt insertion may be required.

Use of corticosteroid in acute bacterial meningitis

The findings are currently inconclusive, as evidenced by 3 different recent meta-analyses:

  1. Reports published from 1966–2008 of placebo-controlled randomized trials of corticosteroid use in the treatment of adolescents and adults with acute bacterial meningitis. The administration of corticosteroids resulted in a lower short-term mortality rate than did the administration of placebo in high-income countries and in the studies with a low prevalence of infection with HIV. In studies from high-income countries, the number needed to treat with corticosteriods to prevent 1 death and 1 neurologic sequela was 12.5 and 11 respectively.
  1. Treatment with dexamethasone was associated with a non-significant lower mortality than placebo or no treatment. Dexamethasone was associated with lower mortality in patients with definite meningitis, short duration of symptoms, Streptococcus pneumoniae meningitis and patients in countries with medium to high Human Development Index. Dexamethasone was associated with fewer episodes of hearing impairment in high quality randomized-controlled trials.
  1. Dexamethasone was not associated with a significant reduction in death, severe neurological sequelae or hearing impairment. However, dexamethasone seemed to reduce hearing loss among survivors. Dexamethasone had no effect in any of the prespecified subgroups, including specific causative organisms, pre-dexamethasone antibiotic treatment, HIV status, or age. Pooling of the mortality data with those of all other published trials did not significantly change the results.

The benefit of adjunctive dexamethasone for all or any subgroup of patients with bacterial meningitis thus remains unproven.

Use of corticosteroids in tuberculous meningitis

Tuberculous meningitis is associated with high mortality and disability among survivors. In a recent review, 7 trials involving 1140 patients (with 411 deaths) with tuberculosis meningitis were analyzed. All used dexamethasone or prednisolone. Overall, corticosteroids reduced the risk of death (RR 0.78, 95% CI 0.67 to 0.91; 1140 participants, 7 trials). Data on disabling residual neurological deficit from 3 trials revealed that corticosteroids reduce the risk of death or disabling residual neurological deficit (RR 0.82, 95% CI 0.70 to 0.97; 720 participants, 3 trials). Adverse events included gastrointestinal bleeding, bacterial and fungal infections and hyperglycaemia, but they were mild and treatable.

Corticosteroids should be routinely used in HIV-negative patients with tuberculous meningitis to reduce death and disabling residual neurological deficit amongst survivors. However, there is not enough evidence to support or refute a similar conclusion for those who are HIV-positive.

Indications of post-exposure prophylaxis

Close contacts of patients suffering from infection due to certain microorganisms such as Haemophilus influenzae type b and Neisseria meningitidis require chemoprophylaxis (e.g. rifampicin or ciprofloxacin).

Encephalitis

Tuesday, June 3rd, 2014

A. Clinical manifestations

The clinical manifestations of encephalitis may be similar to those of meningitis. However, altered level of consciousness is a predominant sign. It can range from mild lethargy to deep coma. Moreover, focal or generalized seizures occur in many patients with encephalitis, especially in severe disease. Virtually every possible type of focal neurological disturbances has been reported.

B. Aetiology

Encephalitis is most frequently due to viral infection. Herpes viruses (herpes simplex and varicella-zoster viruses) and enteroviruses are the commonest agents. Other viruses such as influenza virus, adenovirus, mumps virus, cytomegalovirus, Epstein-Barr virus, HIV, flaviviruses (e.g. Japanese encephalitis virus, West Nile virus) and rabies virus are potential causes.

Bacteria, fungi and parasites can also cause encephalitis – but these are far less common as a cause compared with viruses. Examples include Bartonella spp., Borrelia burgdorferi (Lyme disease), Listeria monocytogenes, Mycobacterium tuberculosis, Cryptococcus neoformans, and Toxoplasma gondii.

C. Diagnosis

Examination of the CSF usually shows pleocytosis with predominantly mononuclear cells, mildly elevated protein and normal glucose. Since the commonest aetiological agents are viral in origin, CSF should be sent for viral culture; PCR/RT-PCR for herpesviruses, enteroviruses, and other suspected viruses. In cases of suspected Japanese B encephalitis, serum and CSF should also be sent for Japanese B virus specific IgM antibodies.

Imaging studies (CT or MRI) of the brain is useful as some of the viral encephalitis have specific imaging findings. For example, in Herpes simplex virus encephalitis, temporal lobe is the most commonly affected area (Figure 1) whereas in Japanese encephalitis, the basal ganglia and thalami (especially bilaterally) are more frequently involved (Figure 2). In addition, electroencephalograms (EEG) may also reveal features suggestive of viral encephalitis, e.g. periodic lateralising epileptiform discharges.

Figure 1. Cerebral MRI of patient with HSV-2 encephalitis showing bilateral temporal lobe hyperintensity

Figure 2. Cerebral MRI of patient with Japanese B encephalitis, showing bilateral thalamic hyperintensity

D. Management

Patients with encephalitis can deteriorate rapidly and so they should be closely monitored. Complications such as increased intra-cranial pressure, seizures, and autonomic dysfunction can occur.

Viral encephalitis, the most common cause, has limited antiviral drugs with proven efficacy. Acyclovir and related compounds are the most effective antiviral agents for herpes virus infection (HSV and VZV). Supportive measures are the mainstay of treatment for most encephalitis cases.

Brain Abscess

Tuesday, June 3rd, 2014

A. Clinical manifestations

The clinical course of brain abscess ranges from indolent to fulminant. Most clinical manifestations are not due to the systemic signs of infection, but rather to the size and site of the abscess. Headache is the most common presenting symptom. Other symptoms and signs include changes in mental status, focal neurological deficits, fever, seizures, and increase intracranial pressure.

According to animal studies, four stages of brain abscess formation evolution were observed: early cerebritis (days 1–3), late cerebritis (days 4–9), early capsule formation (days 10–13) and late capsule formation (day 14 and later). The early cerebritis stage is characterized by an acute inflammatory infiltrate with visible bacteria on Gram stain and marked oedema surrounding the lesion. The centre of the lesion becomes necrotic during the late cerebritis stage. With early capsule formation, the necrotic centre begins to decrease in size with simultaneous development of a collagenous capsule in which it increased in density and thickness during the late capsule formation stage.

B. Aetiology

The aetiological agents of brain abscess depend on the underlying predisposition.

Predisposing conditions Micro-organisms
Otitis media, mastoiditis Streptococci (aerobic and anaerobic), Bacteroides and Prevotella spp., Enterobacteriaceae.
Sinusitis Streptococci (aerobic and anaerobic), Bacteroides, c, Staphylococcus aureus, Haemophilus spp.
Dental infection Mixed anaerobes with Fusobacterium, Prevotella, Actinomyces, and Bacteroides spp., streptococci.
Penetrating trauma orpost-surgery Staphylococcus aureus, streptococci, Enterobacteriaceae, Propionibacterium acnes.
Lung abscess, empyema, bronchiectasis, Anaerobes such as Fusobacterium, Actinomyces, Bacteroides, also streptococci, Nocardia spp.
Infective endocarditis Staphylococcus aureus, streptococci.
HIV infection Toxoplasma gondii, Nocardia spp., Mycobacterium spp., Listeria monocytogenes, Cryptococcus neoformans.

C. Diagnosis

Imaging studies (CT and MRI) are the most important investigations in the diagnosis of brain abscess. The characteristic CT appearance of brain abscess is that of a hypodense centre with a peripheral uniform ring enhancement after the injection of contrast. This is surrounded by a variable hypodense area of brain oedema. However, CT may not be able to pick up the early cerebritis phase. MRI is superior and more sensitive than CT and offers significant advantages in the early detection of cerebritis. In T1-weighted images, the abscess capsule often appears as a discrete rim that is isointense to mild hyperintense, together with contrast enhancement with the paramagnetic agent (Figure 1).

Figure 1. Contrast enhanced T1 cerebral MRI showing left parietal brain abscess with a hyperintense, contrast enhancing rim.

Stereotactic CT-guided aspiration or incision and drainage (I & D) performed in the operating theatre are essential to aid microbiological diagnosis. Gram stain and culture of the abscess fluid can help identify the pathological organism and thus guide anti-microbial therapy.

D. Management

Antibiotics with coverage of both aerobic and anaerobic bacteria (initially empirical, based on assessment of underlying predisposing factors) and measures for prevention of complications (e.g. use of anti-convulsants in patients with seizures, intravenous mannitol and intravenous steroids in patients with cerebral oedema) should be initiated as soon as possible. Occasionally, serological investigations such as serum cryptococcal antigen and Toxoplasma antibody might be helpful in identifying the causative pathogens.

Subdural Empyema and Epidural Abscess

Tuesday, June 3rd, 2014

A. Clinical manifestations

  1. Cranial subdural empyema: fever, headache, altered mental status, symptoms and signs of raised intra-cranial pressure, meningeal irritation or focal irritation.
  1. Spinal subdural empyema: back pain, radiculopathy and spinal cord compression.
  1. Cranial epidural abscess: fever and headache (can be quite asymptomatic), focal neurological signs and seizures, raised intra-cranial pressure.
  1. Spinal epidural abscess: back pain, radiculopathy and spinal cord compression.

B. Aetiology

  1. Cranial subdural empyema: polymicrobial infection is common and includes aerobic streptococci, staphylococci, aerobic Gram negative bacilli, anaerobic streptococci and other anaerobes. Propionibacterium acnes is also common especially in conditions related to trauma, neurosurgical procedures or use of dural grafts.
  1. Spinal subdural empyema: a rare condition usually secondary to metastatic infection from a distant site. The most common isolates are Staphylococcus aureus, streptococci and Gram negative bacilli.
  1. Cranial epidural abscess: similar to cranial subdural empyema.
  1. Spinal epidural abscess: usually secondary to haematogenous dissemination from foci elsewhere in the body or by local extension from vertebral osteomyelitis. The most common agent is Staphylococcus aureus, follow by aerobic and anaerobic streptococci, aerobic Gram negative bacilli, especially E. coli and Pseudomonas aeruginosa.

C. Diagnosis and management

Imaging modalities followed by aspiration or drainage of the empyema or abscess. Antibiotics should be guided initially by underlying predisposing factors and later by culture results.